{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:39:02Z","timestamp":1790127542544,"version":"4.0.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s5218","type":"journal-article","created":{"date-parts":[[2010,9,10]],"date-time":"2010-09-10T04:22:20Z","timestamp":1284092540000},"page":"585","source":"Crossref","is-referenced-by-count":18,"title":["Natalizumab in the treatment of multiple sclerosis"],"prefix":"10.2147","author":[{"given":"Brandon","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=5118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:03:00Z","timestamp":1477864980000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/natalizumab-in-the-treatment-of-multiple-sclerosis-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s5218","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}